Senior Accountant
$95k/y-$120k/y
Radionetics Oncology20 hours ago
Highlight
HybridFull-timeMid
Summary
Radionetics Oncology is seeking a Senior Accountant to join their team in San Diego, CA. The role involves managing day-to-day financial operations, including month-end close processes and accounts payable functions.
About the Role
As a Senior Accountant, you will be responsible for assisting with month-end, quarterly, and year-end close procedures, preparing journal entries and account reconciliations, overseeing purchasing workflows, managing accounts payable, maintaining internal controls, processing payroll, supporting audit processes, and assisting with clinical trial accounting. You will also support special projects for the Controller and CFO.
About You
Required:
- BA/BS in Accounting; CPA license is required.
- 2–4 years of progressive accounting experience, with public accounting experience.
Preferred:
- Previous experience in the Life Sciences/Biotech sector, specifically regarding clinical trial accruals and R&D accounting.
- Strong understanding of U.S. GAAP and SOX compliance.
- Proficiency in Excel (advanced formulas, pivot tables) and experience with Quickbooks, Prendio, Bill.com, Expensify.
Benefits
- Competitive total compensation package including bonus opportunity and equity.
- Medical, dental, vision, life, short-term, and long-term disability insurance.
- 401(k) retirement plan with employer match.
- 4 weeks of paid time off (PTO) annually and generous paid holidays.
Radionetics Oncology
Radionetics Oncology, Inc. is a clinical stage radiopharmaceutical company focused on the discovery and development of novel radiopharmaceuticals for the treatment of a wide range of oncology indications and is poised to capitalize on the increasing demand for novel radiotherapeutics. Radionetics Oncology is supported by Frazier Life Sciences, 5AM Ventures, DCVC Bio, Crinetics Pharmaceuticals, and GordonMD Global Investments and has entered into a strategic agreement with Eli Lilly. Radionetics is advancing a pipeline of first-in-class small molecule radioligands targeting G protein coupled receptors for the treatment of a broad range of cancers, including breast cancer, lung cancer, and other indications of high unmet need.
San Diego, CA